Comparing Gilteritinib vs Midostaurin
| Gilteritinib | Midostaurin |
|
|---|
| Gilteritinib | Midostaurin |
|
|---|---|---|
|
Prescription only
Prescribed for Acute Myeloid Leukemia. Gilteritinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Systemic Mastocytosis, Acute Myeloid Leukemia. Midostaurin may also be used for purposes not listed in this medication guide. |
Related suggestions Acute Myeloid Leukemia
|
| More about Gilteritinib | More about Midostaurin | |
| Ratings & Reviews | ||
|
Gilteritinib has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Midostaurin has an average rating of 7.4 out of 10 from a total of 5 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 20% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Gilteritinib side effects |
View all Midostaurin side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Xospata | Rydapt | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
113 hours |
482 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 500 drugs are known to interact with Gilteritinib:
|
A total of 653 drugs are known to interact with Midostaurin:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
November 28, 2018 |
April 28, 2017 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Xospata
Xospata (gilteritinib) is used to treat acute myeloid leukemia (AML) with a FLT3 mutation. Xospata ...
Revuforj
Revuforj is used to treat acute leukemia with a lysine methyltransferase 2A gene translocation ...
Vanflyta
Vanflyta (quizartinib) is an oral targeted treatment called a kinase inhibitor that may be used to ...
Idhifa
Idhifa (enasidenib) is used to treat acute myeloid leukemia in adults who have a mutation in the ...
Onureg
Onureg (azacitidine) is used for the continued treatment of adult patients with acute myeloid ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.